Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent

References

• Almeida, A.J., Runge, S., Muller, R.H. (1997). Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int J Pharm. 149:255–65.
   Web of Science ®Google Scholar
• Boltri, L., Canal, T., Esposito, P.A., Carli, F. (1993). Lipid nanoparticles: evaluation of some critical formulation parameters. Proc Int Symp Contr Rel Bioact Mater. 20:346–7.
   Google Scholar
• Chen, H.B., Chang, X.L., Yang, X.L., Du, D.R., Liu, W., Liu, J., Weng, T., Yang, Y.J., Xu, H.B. (2006). Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Contr Rel. 110:296–306.
   PubMed Web of Science ®Google Scholar
• Draize, J., Woodard, G., Calvery, H. (1944). Methods for the study of irritation and toxicity of substances topically applied to skin and mucous membranes. J Pharmacol Exp Ther. 82:377–90.
   Web of Science ®Google Scholar
• Evren, H.G., Giuseppina, S.M., Cristina, B., Silvia, R., Franca, F., Tamer, G., Carla, C. (2008). Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. Int J Pharm. 364:76–86.
   PubMedGoogle Scholar
• Goymann, M.C., Schubert, M.A. (2003). Solvent injection as a new approach for manufacturing lipid nanoparticles—evaluation of the method and process parameters. Eur J Pharm Biopharm. 55:125–31.
   PubMed Web of Science ®Google Scholar
• Jain, S.K., Chourasia, M.K., Masuriha, R., Soni, V., Jain, A., Jain, N.K., Gupta, Y. (2005). Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Deliv. 12:207–15.
   PubMed Web of Science ®Google Scholar
• Jenning, V., Gysler, A., Schafer-Korting, M., Gohla, S.H. (2000). Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 49:211–8.
   PubMed Web of Science ®Google Scholar
• Joshi, M., Patravale, V. (2006). Formulation and evaluation of nanostructured lipid carrier (NLC)-based hydrogel of valdecoxib. Drug Dev Ind Pharm. 32:911–8.
   PubMed Web of Science ®Google Scholar
• Maebashi, K., Itoyama, T., Uchida, K., Yamaguchi, H. (1995). A novel model of cutaneous candidiasis produced in prednisolone-treated guinea pigs. J Med Vet Mycol. 19:390–2.
   Google Scholar
• Maia, C.S., Mehnert, W., Schafer-Korting, M. (2000). Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm. 196:165–7.
   PubMed Web of Science ®Google Scholar
• Muller, R.H., Mader, K., Gohla, S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery—review of the state of the art. Eur J Pharm Biopharm. 50:161–77.
   PubMed Web of Science ®Google Scholar
• Pedersen, M., Edelsten, M., Nielsen, V.F., Scarpelline, A., Skytte, S., Slot, C. (1993). Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole. Int J Pharm. 90:247–54.
   Web of Science ®Google Scholar
• Peira, E., Eugenia, M., Trotta, C.C., Cavalli, R., Trotta, M. (2008). Positively charged microemulsions for topical application. Int J Pharm. 346:119–23.
   PubMed Web of Science ®Google Scholar
• Pershing, L.K., Corlett, L.J., Jorgensen, C. (1994). In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum, Antimicrob. Agents Chemother. 38:90–5.
   PubMed Web of Science ®Google Scholar
• Puglia, C., Filosa, R., Peduto, A., Caprariis, P., Rizza, L., Bonina, F., Blasi, P. (2006). Evaluation of alternative strategies to optimize ketorolac transdermal delivery. AAPS Pharm Sci Tech. 7:E1–9.
   PubMed Web of Science ®Google Scholar
• Shah, K.A., Patravale, V.B., Date, A., Joshi, M.D. (2007). Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm. 345:163–71.
   PubMed Web of Science ®Google Scholar
• Siekmann, B., Westesen, K. (1992). Submicron-sized parental carrier system based on solid lipids. Pharm Pharmacol Lett. 1:123–6.
   Google Scholar
• Sivaramakrishnan, R., Nakamura, C., Mehnert, W., Korting, H.C., Kramer, K.D., Schafer-Korting, M. (2004). Glucocorticoids entrapment into lipid carriers—characterization by parelectic spectroscopy and influence on dermal uptake. J Contr Rel. 97:493–502.
   PubMed Web of Science ®Google Scholar
• Song, C., Liu, S. (2005). A new healthy sunscreen system for human: solid lipid nanoparticles as carrier for 3, 4, 5-trimethoxybenzoylchitin and the improvement by adding Vitamin E. Int J Biol Macromol. 36:116–9.
   PubMed Web of Science ®Google Scholar
• Sylvia, A., Muller, R.H., Wissing, S.A. (2003). Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm. 254:65–8.
   PubMed Web of Science ®Google Scholar
• Wissing, S.A., Muller, R.H. (2001). A novel sunscreen system based on tocopherol acetate incorporated into solid lipid nanoparticles. Int J Cos Sci. 23:233–43.
   PubMedGoogle Scholar
• Wissing, S.A., Muller, R.H. (2002a). Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Contr Rel. 81:225–33.
   PubMed Web of Science ®Google Scholar
• Wissing, S.A., Muller, R.H. (2002b). The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int J Pharm. 242:377–9.
   PubMed Web of Science ®Google Scholar
• Wissing, S.A., Muller, R.H. (2003). The influence of solid lipid nanoparticles on skin hydration and viscoelasticity—in vivo study. Eur J Pharm Biopharm. 56:67–72.
   PubMed Web of Science ®Google Scholar
• Zhinan, M., Qunrong, W., Sheng, H., Xiaokuan, L., Xiangliang, Y. (2005). Triptolide loaded solid lipid nanoparticles hydrogel for topical application. Drug Dev Ind Pharm. 31:161–8.
   PubMed Web of Science ®Google Scholar
• Zur Muhlen, A., Schwarz, C., Mehnert, W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery—drug release and release mechanism. Eur J Pharm Biopharm. 45: 149–55.
   PubMed Web of Science ®Google Scholar